Skip to content

Technical panel formed in the aftermath of Maiden Pharma case likely to probe Marion Biotech case too

 A spate of allegations that contaminated drugs were being exported to countries with weak drug regulatory mechanisms indicates that larger reforms may be needed

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish